255 related articles for article (PubMed ID: 6090847)
1. Opioid control of the ruminant stomach motility: functional importance of mu, kappa and delta receptors.
Ruckebusch Y; Bardon T; Pairet M
Life Sci; 1984 Oct; 35(17):1731-8. PubMed ID: 6090847
[TBL] [Abstract][Full Text] [Related]
2. Opioid receptor agonists in the rabbit colon: comparison of in vivo and in vitro studies.
Pairet M; Ruckebusch Y
Life Sci; 1984 Oct; 35(16):1653-8. PubMed ID: 6148681
[TBL] [Abstract][Full Text] [Related]
3. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
Ramme D; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418
[TBL] [Abstract][Full Text] [Related]
5. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
6. TENA, a selective kappa opioid receptor antagonist.
Portoghese PS; Takemori AE
Life Sci; 1985 Feb; 36(8):801-5. PubMed ID: 2983171
[TBL] [Abstract][Full Text] [Related]
7. Mu and delta, but not kappa, opioid agonists induce contractions of the canine small intestine in vivo.
Vaught JL; Cowan A; Jacoby HI
Eur J Pharmacol; 1985 Feb; 109(1):43-8. PubMed ID: 2859995
[TBL] [Abstract][Full Text] [Related]
8. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
9. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
Tavani A; Petrillo P; La Regina A; Sbacchi M
J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
[TBL] [Abstract][Full Text] [Related]
10. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
Takemori AE; Ho BY; Naeseth JS; Portoghese PS
J Pharmacol Exp Ther; 1988 Jul; 246(1):255-8. PubMed ID: 2839664
[TBL] [Abstract][Full Text] [Related]
11. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
Fang FG; Fields HL; Lee NM
J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
[TBL] [Abstract][Full Text] [Related]
12. Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo.
Hirning LD; Porreca F; Burks TF
Eur J Pharmacol; 1985 Feb; 109(1):49-54. PubMed ID: 2986990
[TBL] [Abstract][Full Text] [Related]
13. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit.
Jackisch R; Geppert M; Illes P
J Neurochem; 1986 Jun; 46(6):1802-10. PubMed ID: 2871130
[TBL] [Abstract][Full Text] [Related]
14. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
Gué M; Junien JL; Bueno L
J Pharmacol Exp Ther; 1989 Sep; 250(3):1006-10. PubMed ID: 2550612
[TBL] [Abstract][Full Text] [Related]
15. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
16. Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats.
Satoh M; Kubota A; Iwama T; Wada T; Yasui M; Fujibayashi K; Takagi H
Life Sci; 1983; 33 Suppl 1():689-92. PubMed ID: 6141508
[TBL] [Abstract][Full Text] [Related]
17. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
Iyengar S; Kim HS; Wood PL
Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
19. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
Dray A; Metsch R
Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211
[TBL] [Abstract][Full Text] [Related]
20. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
Locke KW; Gorney B; Cornfeldt M; Fielding S
Psychopharmacology (Berl); 1989; 99(4):492-6. PubMed ID: 2556726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
